O. Lyon‐Caen - Concepedia

Author

O. Lyon‐Caen

Also Known As

John King, Lyon-Caen, Olivier, O LYONCAEN, O Lyon-Caen, O Lyon-Caeń, O Lyoncaen, O. Lyon-Caen, O. Lyoncaen, O. Lyon‐Caen, Olivier Lyon-Caen

142

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Pitié-Salpêtrière Hospital Inserm Centre National de la Recherche Scientifique Institut Pasteur

About

O. Lyon‐Caen is an author at Sorbonne Université specializing in medicine, multiple sclerosis, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	2.3K
2	Health Sciences	4	4	692
3	Natural Sciences	1	1	60
4	Public Health	1	1	42
5	Social Sciences	1	1	24

O. Lyon‐Caen

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Clinical spectrum of CADASIL: a study of 7 families Hugues Chabriat, Katayoun Vahedi, M G Bousser, The Lancet Family MedicineClinical FindingHistopathologyClinical EvidenceCase Series	1995	667
Paramedian thalamic and midbrain infarcts: Clinical and neuropathological study P Castaigne, F Lhermitte, A Buge, Annals of Neurology ThrombosisHealth SciencesNeuroanatomyMedicineBasilar Artery	1981	560
Spinocerebellar ataxia 3 and machado‐joseph disease: Clinical, molecular, and neuropathological features Alexandra Dürr, Giovanni Stévanin, Géraldine Cancel‐Tassin, Annals of Neurology	1996	446
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. Gilles Edan, David Miller, M. Clanet, Journal of Neurology Neurosurgery & Psychiatry	1997	422
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring Ludwig Kappos, David O. Bates, Gilles Edan, The Lancet Neurology Translational MedicineSystemic SclerodermaMedicineImmunologyClinical Trials	2011	265
High doses of biotin in chronic progressive multiple sclerosis: A pilot study Frédéric Sedel, Caroline Papeix, Agnès Bellanger, Multiple Sclerosis and Related Disorders	2015	219
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica Caroline Papeix, Jean‐Sébastien Vidal, J. de Sèze, Multiple Sclerosis Journal Clinical ImmunologyOcular DiseaseNeurological DisorderImmunodeficienciesImmunology	2007	204
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p Jamïlé Hazan, Bertrand Fontaine, R.P.M. Bruyn, Human Molecular Genetics	1994	143
A Longitudinal Study of Callosal Atrophy and Interhemispheric Dysfunction in Relapsing-Remitting Multiple Sclerosis Jean Pelletier, Laurent Suchet, Tatiana Witjas, Archives of Neurology	2001	140
Eating Disorder and Metabolism in Narcoleptic Patients Dorothée Chabas, Christine Foulon, Jesús González, SLEEP	2007	133

Page 1